
GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is Certified Aminos' research listing for a synthetic hexapeptide that activates the growth hormone secretagogue receptor (GHSR-1a), the same receptor bound by endogenous ghrelin. Available in 10mg for laboratory research use only.
HPLC certified
Independent analysis
Highest standard
Full traceability
Each order ships as a GHRP-6 research peptide in a 10mg vial, manufactured for laboratory use only.
| Compound | GHRP-6 (Growth Hormone-Releasing Peptide-6) |
|---|---|
| Sequence | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 -- confirmed by the original 1984 pharmacological characterization |
| Receptor Target | GHSR-1a (growth hormone secretagogue receptor), shared with endogenous ghrelin |
| Related Compound Distinction | A three-way comparison found GHRP-2 more potent per dose than GHRP-6 or ipamorelin in swine, but with lower maximal efficacy; both GHRP-6 and GHRP-2 raised ACTH/cortisol, while ipamorelin notably did not |
| CAS Number / Molecular Weight | Not stated on this listing -- not independently confirmed |
| Available Size | 10mg |
| Purity | Not independently verified -- no batch-specific COA is currently published |
| Identity | Not independently confirmed by mass spectrometry or an equivalent method |
| Intended Use | Laboratory research only (RUO) |
When your order arrives, match the lot number printed on the vial to the lot number on the COA before beginning any work. Until a batch-specific COA is published for this product, treat any purity or identity figure shown elsewhere on this listing as a supplier claim, not an independently verified result.

HCG and LH bind the exact same receptor — yet research shows they send measurably different signals once they do. Here's what's actually established about HCG's structure, mechanism, and the FDA's position on HCG weight-loss claims.

No peer-reviewed human study of IGF-1 LR3 exists — a 2026 literature review placed it in its lowest evidence tier. Here's what the cell and animal research actually shows, and where it stops.

BPC-157 sits in a different WADA category than TB-500 or ipamorelin — and that difference actually matters if you're trying to understand the rules. Here's the 2026 list, compound by compound, with the official source for each.